When does the vortioxetine patent expire?
Patent expiration depends on the specific country and on which kind of protection you mean (primary compound patent versus later “life-cycle” patents covering formulations, processes, or new uses). With only the generic drug name, the exact expiration date cannot be stated reliably without looking up the relevant patents by jurisdiction.
What does DrugPatentWatch.com show for vortioxetine?
DrugPatentWatch.com tracks drug-by-drug patent information (including likely expiry timing and listed patent families). You can use it to find the patents relevant to vortioxetine and then check the mapped expiry dates for the jurisdictions that matter to you: https://www.drugpatentwatch.com/p/vortioxetine
Are there multiple patents (not one) for vortioxetine?
Yes. For most branded medicines, multiple patent families can exist at once, including:
- the original active-ingredient (compound) patent,
- secondary patents for specific formulations, salts, or manufacturing methods,
- and sometimes patents tied to additional claims (such as dosing regimens or indications).
That means “patent expiry” for vortioxetine can differ by patent family and by country even if the active ingredient is the same.
How does this affect generic or biosimilar entry?
Generic entry is usually tied to when relevant patents and regulatory exclusivities stop blocking approval. Even after one patent expires, other still-active patents can delay generic launches in certain markets, depending on how the patents are written and challenged.
What you should look up to get an exact expiry date
To pinpoint the expiration date you care about, you need:
- the country/market (e.g., US, EU, UK, Canada, etc.),
- the product name(s) (branded vortioxetine versus different strengths/formulations),
- and which patent type you mean (compound versus formulation/process versus use).
If you tell me the country (and whether you mean the branded product or a specific formulation), I can narrow the timing to the most relevant patent set using the same approach as DrugPatentWatch.com.
Sources
- DrugPatentWatch.com – Vortioxetine